DM199 for Pregnancy Complications

Last updated: May 30, 2025
Sponsor: DiaMedica Therapeutics Inc
Overall Status: Trial Not Available

Phase

N/A

Condition

Birth Defects

Pregnancy Complications

Preeclampsia

Treatment

DM199

Clinical Study ID

NCT06875141
PACTR202404895013782
PACTR202404895013782
  • Ages 18-50
  • Female

Study Summary

This entry was submitted in error by DiaMedica Therapeutics, Inc. and was not authorized by any of the trial Investigators or study sponsor (Stellenbosch University).

The clinical trial, DM199 for Pregnancy Complications, was prospectively registered with the Pan African Clinical Trials Registry (PACTR202404895013782), in accordance with ICMJE and WHO requirements. This listing serves as the primary and authoritative registration record for this investigator-initiated study.

Eligibility Criteria

Inclusion

Please refer to the Pan African Clinical Trials Registry (PACTR202404895013782).

Study Design

Treatment Group(s): 1
Primary Treatment: DM199
Phase:
Study Start date:
May 01, 2025
Estimated Completion Date:
May 31, 2025

Connect with a study center

  • Preeclampsia Research Institute, Department of Obstetrics and Gynaecology, Stellenbosch University,

    Tygerberg, CapeTown 7505
    South Africa

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.